{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:37:17Z","timestamp":1747179437598,"version":"3.40.5"},"reference-count":60,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2024,5,3]]},"DOI":"10.1080\/17425255.2024.2348488","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T13:33:47Z","timestamp":1714138427000},"page":"307-317","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what\u2019s new?"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2139-1448","authenticated-orcid":false,"given":"Shilan","family":"Mozaffari","sequence":"first","affiliation":[{"name":"Department of Toxicology and Pharmacology, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5206-6197","authenticated-orcid":false,"given":"Shekoufeh","family":"Nikfar","sequence":"additional","affiliation":[{"name":"Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Personalized Medicine Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0123-1209","authenticated-orcid":false,"given":"Mohammad","family":"Abdollahi","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Pharmacology, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.02.029"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.04.017"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i26.4120"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-017-0611-2"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200624010-00002"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2013.19.9.755"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1767067"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.759558"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01116-z"},{"issue":"1","key":"e_1_3_5_12_1","first-page":"15","article-title":"The role of loperamide in gastrointestinal disorders","volume":"8","author":"Hanauer SB","year":"2008","unstructured":"Hanauer SB. The role of loperamide in gastrointestinal disorders. Rev Gastroenterol Disord. 2008;8(1):15\u201320.","journal-title":"Rev Gastroenterol Disord"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172846"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024361"},{"key":"e_1_3_5_15_1","unstructured":"Eluxadoline FDA label [Internet]. 2018. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/206940s003lbl.pdf"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S216056"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505180"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S127405"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-018-2008-z"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000327"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1204"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239127"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.542"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.01.026"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.236547"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/164_2016_119"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.964"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.442"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2023.2273384"},{"issue":"2","key":"e_1_3_5_30_1","first-page":"S25","article-title":"Serotonin and its implication for the management of irritable bowel syndrome","volume":"3","author":"Gershon MD","year":"2003","unstructured":"Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord. 2003;3(Suppl 2):S25\u201334.","journal-title":"Rev Gastroenterol Disord"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2007.00965.x"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1533456"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00157-6"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.05.002"},{"key":"e_1_3_5_35_1","unstructured":"Alosetron FDA label [Internet]. 2019. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021107s029lbl.pdf"},{"key":"e_1_3_5_36_1","volume-title":"StatPearls","author":"Butt I","year":"2023","unstructured":"Butt I, Alosetron KF. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2023, StatPearls Publishing LLC.; 2023."},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02031.x"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01565.x"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14948"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00459.x"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X13491798"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1150"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44807"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2018.1488964"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2016.1140571"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(15)32236-8"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X17726087"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.629026"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2023.01.010"},{"key":"e_1_3_5_50_1","unstructured":"Rifaximin FDA label [Internet]. 2023. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/021361s031lbl.pdf"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12735"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1186639"},{"issue":"10","key":"e_1_3_5_53_1","first-page":"1314","article-title":"Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome","volume":"17","author":"Scarpellini E","year":"2013","unstructured":"Scarpellini E, Giorgio V, Gabrielli M, et al. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2013;17(10):1314\u20131320.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181effa3b"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.10.1361"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H395"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072558"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0286-8"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01201-3"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-020-00308-5"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0646-2"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/109158101317097728"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2024.2348488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T13:02:42Z","timestamp":1727269362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2024.2348488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,3]]}},"alternative-id":["10.1080\/17425255.2024.2348488"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2024.2348488","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"type":"print","value":"1742-5255"},{"type":"electronic","value":"1744-7607"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}